ETF Holdings Breakdown of ARDX

News associated with ARDX

HC Wainwright Forecasts Ardelyx’s Q2 Earnings (NASDAQ:ARDX)

Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – HC Wainwright issued their Q2 2025 earnings per share estimates for Ardelyx in a research note issued to investors on Wednesday, June 18th. HC Wainwright analyst M. Caufield anticipates that the biopharmaceutical company will post earnings per share of ($0.14) for the quarter. HC Wainwright has a “Buy” […] - 2025-06-24 05:24:51

World Equity Group Inc. Acquires New Shares in Ardelyx, Inc. (NASDAQ:ARDX)

World Equity Group Inc. bought a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 17,400 shares of the biopharmaceutical company’s stock, valued at approximately $85,000. Other large investors have also bought and sold […] - 2025-06-23 08:36:49

SG Americas Securities LLC Buys 111,457 Shares of Ardelyx, Inc. (NASDAQ:ARDX)

SG Americas Securities LLC boosted its stake in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 203.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 166,343 shares of the biopharmaceutical company’s stock after buying an additional 111,457 shares during the quarter. SG Americas Securities LLC’s holdings in Ardelyx were worth $817,000 as of its […] - 2025-06-20 08:12:54

Ardelyx (NASDAQ:ARDX) Now Covered by HC Wainwright

Investment analysts at HC Wainwright initiated coverage on shares of Ardelyx (NASDAQ:ARDX – Get Free Report) in a research note issued on Wednesday, Marketbeat.com reports. The brokerage set a “buy” rating and a $10.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 177.01% from the stock’s previous […] - 2025-06-20 05:15:21

Ardelyx, Inc. (NASDAQ:ARDX) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on […] - 2025-06-05 05:48:52

Mackenzie Financial Corp Purchases 101,841 Shares of Ardelyx, Inc. (NASDAQ:ARDX)

Mackenzie Financial Corp raised its position in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 266.0% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 140,133 shares of the biopharmaceutical company’s stock after acquiring an additional 101,841 shares during the period. Mackenzie Financial Corp’s holdings in Ardelyx were worth $710,000 as of its most recent […] - 2025-06-02 08:49:04

Two Sigma Advisers LP Increases Position in Ardelyx, Inc. (NASDAQ:ARDX)

Two Sigma Advisers LP grew its stake in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 206.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 593,700 shares of the biopharmaceutical company’s stock after acquiring an additional 400,100 shares during the quarter. Two Sigma Advisers […] - 2025-05-28 09:23:01

ProShare Advisors LLC Acquires 19,643 Shares of Ardelyx, Inc. (NASDAQ:ARDX)

ProShare Advisors LLC lifted its holdings in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 34.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 77,469 shares of the biopharmaceutical company’s stock after buying an additional 19,643 shares during the period. ProShare […] - 2025-05-28 07:54:54

Ardelyx, Inc. (NASDAQ:ARDX) Shares Purchased by Two Sigma Investments LP

Two Sigma Investments LP grew its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 16.0% in the 4th quarter, Holdings Channel reports. The fund owned 1,141,777 shares of the biopharmaceutical company’s stock after acquiring an additional 157,416 shares during the period. Two Sigma Investments LP’s holdings in Ardelyx were worth $5,789,000 as […] - 2025-05-27 08:29:06

Analysts Set Ardelyx, Inc. (NASDAQ:ARDX) Target Price at $10.39

Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating […] - 2025-05-14 05:34:50

126,530 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Acquired by Tudor Investment Corp ET AL

Tudor Investment Corp ET AL purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 126,530 shares of the biopharmaceutical company’s stock, valued at approximately $642,000. Tudor Investment Corp ET AL owned about […] - 2025-05-08 09:12:50

First Trust Advisors LP Sells 305,383 Shares of Ardelyx, Inc. (NASDAQ:ARDX)

First Trust Advisors LP lowered its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 53.2% during the fourth quarter, Holdings Channel reports. The fund owned 268,924 shares of the biopharmaceutical company’s stock after selling 305,383 shares during the period. First Trust Advisors LP’s holdings in Ardelyx were worth $1,363,000 at the end […] - 2025-05-07 08:15:07

Ardelyx (NASDAQ:ARDX) Stock Price Down 8.4% Following Insider Selling

Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) shares dropped 8.4% during trading on Monday after an insider sold shares in the company. The stock traded as low as $3.89 and last traded at $3.79. Approximately 3,550,524 shares were traded during trading, a decline of 18% from the average daily volume of 4,347,468 shares. The stock […] - 2025-05-07 05:23:00

Raymond James Financial Inc. Takes Position in Ardelyx, Inc. (NASDAQ:ARDX)

Raymond James Financial Inc. bought a new stake in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm bought 183,490 shares of the biopharmaceutical company’s stock, valued at approximately $930,000. Several other large investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings […] - 2025-05-06 07:36:46

Ardelyx (NASDAQ:ARDX) Lowered to “Sell” Rating by StockNews.com

StockNews.com cut shares of Ardelyx (NASDAQ:ARDX – Free Report) from a hold rating to a sell rating in a report released on Monday. Other analysts have also recently issued research reports about the stock. LADENBURG THALM/SH SH reissued a “buy” rating and issued a $11.00 price target on shares of Ardelyx in a research note […] - 2025-05-06 05:56:44

Wedbush Estimates Ardelyx’s Q4 Earnings (NASDAQ:ARDX)

Ardelyx, Inc. (NASDAQ:ARDX – Free Report) – Equities research analysts at Wedbush boosted their Q4 2025 earnings estimates for Ardelyx in a research report issued on Friday, May 2nd. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings per share of $0.01 for the quarter, up from their previous estimate of […] - 2025-05-05 07:24:50

Barclays PLC Sells 14,671 Shares of Ardelyx, Inc. (NASDAQ:ARDX)

Barclays PLC reduced its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 532,654 shares of the biopharmaceutical company’s stock after selling 14,671 shares during the period. Barclays PLC’s holdings […] - 2025-05-01 08:12:53

LPL Financial LLC Has $704,000 Position in Ardelyx, Inc. (NASDAQ:ARDX)

LPL Financial LLC lessened its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 29.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 138,804 shares of the biopharmaceutical company’s stock after selling 58,562 shares during the period. LPL Financial LLC’s holdings in Ardelyx were worth […] - 2025-04-23 07:18:48

CreativeOne Wealth LLC Takes $274,000 Position in Ardelyx, Inc. (NASDAQ:ARDX)

CreativeOne Wealth LLC purchased a new position in Ardelyx, Inc. (NASDAQ:ARDX – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 53,993 shares of the biopharmaceutical company’s stock, valued at approximately $274,000. Other institutional investors and hedge funds have also […] - 2025-04-21 08:13:01

Ardelyx Sees Unusually Large Options Volume (NASDAQ:ARDX)

Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Investors purchased 12,093 put options on the company. This is an increase of 411% compared to the typical volume of 2,365 put options. Insider Activity at Ardelyx In other news, Director David M. Mott bought 199,000 shares of […] - 2025-04-11 05:38:57

Ardelyx, Inc. (NASDAQ:ARDX) Shares Acquired by Teacher Retirement System of Texas

Teacher Retirement System of Texas grew its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) by 19.1% in the 4th quarter, HoldingsChannel reports. The firm owned 69,867 shares of the biopharmaceutical company’s stock after acquiring an additional 11,191 shares during the quarter. Teacher Retirement System of Texas’ holdings in Ardelyx were worth $354,000 […] - 2025-04-01 07:44:44

Cibc World Markets Corp Makes New $112,000 Investment in Ardelyx, Inc. (NASDAQ:ARDX)

Cibc World Markets Corp purchased a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 22,015 shares of the biopharmaceutical company’s stock, valued at approximately $112,000. A number of other hedge funds and other […] - 2025-03-28 08:48:47

Ardelyx (NASDAQ:ARDX) Upgraded at Cantor Fitzgerald

Ardelyx (NASDAQ:ARDX – Get Free Report) was upgraded by stock analysts at Cantor Fitzgerald to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports. Other research analysts also recently issued research reports about the company. Citigroup decreased their price objective on Ardelyx from $12.00 to $10.00 and set a “buy” rating on […] - 2025-03-06 08:20:02

Ardelyx, Inc. (NASDAQ:ARDX) Receives $9.93 Consensus Price Target from Brokerages

Shares of Ardelyx, Inc. (NASDAQ:ARDX – Get Free Report) have been assigned a consensus rating of “Buy” from the nine brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating on […] - 2025-02-28 06:26:55

ARDX institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	185,455	USD 683,402
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	22,394	USD 82,522
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	121,158	USD 446,467
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	121,158	USD 446,467
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,020	USD 3,759
Total =		451,185	USD 1,662,617

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer